Short @324 if support is tough buy @334. Market doesn't matter in this situation. But don't go against the scrip trend.
Comment
⋅
Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg.... Expected huge price rise...
Comment
⋅
Don't short now 100% buy Sub: Glenmark receives approval from the regulator (DCGI) to conduct Clinical Trials in India on Favipiravir Antiviral tablets for COVID-19 patients
@Hulk703, yes, only if it is able to sustain and break the resistance at 370. Otherwise there are chances it will again retrace to downfall... I don't see long hopes